GoodRx Holdings Inc (NASDAQ: GDRX)’s stock price has soared by 3.68 in relation to previous closing price of 3.94. Nevertheless, the company has seen a gain of 7.78% in its stock price over the last five trading days. businesswire.com reported 2025-05-22 that SANTA MONICA, Calif.–(BUSINESS WIRE)–GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that it will launch a new offering for independent community pharmacies – GoodRx Community Link – in June 2025. GoodRx Community Link will enable locally owned and operated pharmacies to directly contract with GoodRx on pricing and manage participation in the company’s Integrated Savings Programs (ISP). Direct contracts leverage cost-plus models to provide indep.
Is It Worth Investing in GoodRx Holdings Inc (NASDAQ: GDRX) Right Now?
GoodRx Holdings Inc (NASDAQ: GDRX) has a higher price-to-earnings ratio of 54.98x compared to its average ratio, The 36-month beta value for GDRX is at 1.17. Analysts have varying views on the stock, with 7 analysts rating it as a “buy,” 1 rating it as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for GDRX is 83.51M, and currently, shorts hold a 5.08% of that float. The average trading volume for GDRX on June 04, 2025 was 1.48M shares.
GDRX’s Market Performance
The stock of GoodRx Holdings Inc (GDRX) has seen a 7.78% increase in the past week, with a -12.90% drop in the past month, and a -17.31% fall in the past quarter. The volatility ratio for the week is 2.64%, and the volatility levels for the past 30 days are at 4.84% for GDRX. The simple moving average for the past 20 days is 2.50% for GDRX’s stock, with a -22.85% simple moving average for the past 200 days.
Analysts’ Opinion of GDRX
Many brokerage firms have already submitted their reports for GDRX stocks, with Mizuho repeating the rating for GDRX by listing it as a “Neutral.” The predicted price for GDRX in the upcoming period, according to Mizuho is $5 based on the research report published on December 04, 2024 of the previous year 2024.
Raymond James, on the other hand, stated in their research note that they expect to see GDRX reach a price target of $10. The rating they have provided for GDRX stocks is “Strong Buy” according to the report published on August 09th, 2024.
RBC Capital Mkts gave a rating of “Outperform” to GDRX, setting the target price at $10 in the report published on May 23rd of the previous year.
GDRX Trading at -4.64% from the 50-Day Moving Average
After a stumble in the market that brought GDRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -55.89% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at GDRX starting from Bradley Julie MB, who proposed sale 95,255 shares at the price of $4.95 back on Dec 02 ’24. After this action, Bradley Julie MB now owns shares of GoodRx Holdings Inc, valued at $471,451 using the latest closing price.
Spectrum Equity VII, L.P., the 10% Owner of GoodRx Holdings Inc, sale 10,677 shares at $7.86 during a trade that took place back on Sep 03 ’24, which means that Spectrum Equity VII, L.P. is holding 0 shares at $83,922 based on the most recent closing price.
Stock Fundamentals for GDRX
Current profitability levels for the company are sitting at:
- 0.1 for the present operating margin
- 0.92 for the gross margin
The net margin for GoodRx Holdings Inc stands at 0.06. The total capital return value is set at 0.07. Equity return is now at value 4.43, with 2.07 for asset returns.
Based on GoodRx Holdings Inc (GDRX), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at 2.72. The debt to equity ratio resting at 0.08. The interest coverage ratio of the stock is 2.99.
Currently, EBITDA for the company is 153.92 million with net debt to EBITDA at -1.71. When we switch over and look at the enterprise to sales, we see a ratio of 1.52. The receivables turnover for the company is 4.98for trailing twelve months and the total asset turnover is 0.62. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.23.
Conclusion
In conclusion, GoodRx Holdings Inc (GDRX) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
